MAB381
Anti-Myelin Basic Protein Antibody
CHEMICON®, mouse monoclonal, 2
Synonym(s):
MBP
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Recommended Products
product name
Anti-Myelin Basic Protein Antibody, a.a. 119-131, clone 2, culture supernatant, clone 2, Chemicon®
biological source
mouse
Quality Level
antibody form
culture supernatant
antibody product type
primary antibodies
clone
2, monoclonal
species reactivity
bovine, sheep, human, rat, rabbit, guinea pig
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
immunohistochemistry: suitable
isotype
IgG1
NCBI accession no.
UniProt accession no.
shipped in
dry ice
target post-translational modification
unmodified
Gene Information
human ... MBP(4155)
rat ... Mbp(24547)
Specificity
Reacts with MBP from human, bovine, rabbit, guinea pig, rat, and sheep. The epitope appears to be located in the region of residues 119-131.
Immunogen
Bovine myelin basic protein.
Epitope: a.a. 119-131
Application
Anti-Myelin Basic Protein Antibody, a.a. 119-131, clone 2 is an antibody against Myelin Basic Protein for use in ELISA, IH.
Immunohistochemistry - frozen sections
ELISA
Optimal working dilutions must be determined by end user.
ELISA
Optimal working dilutions must be determined by end user.
Research Category
Neuroscience
Neuroscience
Research Sub Category
Neuronal & Glial Markers
Neurochemistry & Neurotrophins
Neuronal & Glial Markers
Neurochemistry & Neurotrophins
Physical form
Tissue culture supernatant. Liquid in 0.2M Tris/HCl, pH 7.4 with 5-10% fetal calf serum and 0.09% sodium azide.
Storage and Stability
Maintain at -20°C for up to 12 months in undiluted aliquots. Avoid repeated freeze-thaw cycles.
Important Note: During shipment, small volumes of product will occasionally become entrapped in the seal of the product vial. For products with volumes of 200 μL or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container′s cap.
Important Note: During shipment, small volumes of product will occasionally become entrapped in the seal of the product vial. For products with volumes of 200 μL or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container′s cap.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class Code
10 - Combustible liquids
WGK
WGK 3
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis.
Bielecki, B; Jatczak-Pawlik, I; Wolinski, P; Bednarek, A; Glabinski, A
Archivum Immunologiae et Therapiae Experimentalis null
Jens Kuhle et al.
The New England journal of medicine, 356(4), 371-378 (2007-01-26)
Patients with a single episode of neurologic dysfunction and brain magnetic resonance imaging (MRI) scans suggestive of multiple sclerosis are at high risk for clinically definite multiple sclerosis, but the outcome for individual patients is unpredictable. An increased risk of
Kelly Q Zhou et al.
Pediatric research, 88(1), 48-56 (2019-06-25)
Therapeutic hypothermia is partially protective for neonatal hypoxic-ischemic encephalopathy (HIE). Damage to the white matter tracts is highly associated with adverse outcomes after HIE, but the effectiveness and optimal duration of hypothermia to attenuate axonal injury are unclear. Near-term fetal
Guido Wassink et al.
Brain communications, 3(3), fcab172-fcab172 (2021-08-20)
Therapeutic hypothermia for hypoxic-ischaemic encephalopathy provides partial white matter protection. Recombinant erythropoietin reduces demyelination after hypoxia-ischaemia, but it is unclear whether adjunct erythropoietin treatment can further improve outcomes after therapeutic hypothermia. Term-equivalent fetal sheep received sham-ischaemia (n = 9) or cerebral ischaemia
Jan Storek et al.
Clinical immunology (Orlando, Fla.), 113(3), 285-298 (2004-10-28)
To ascertain the consequences of severe leukopenia and the tempo of recovery, we studied the immunity of 56 adult patients treated for multiple sclerosis or systemic sclerosis with autologous CD34 cell transplantation using extremely lymphoablative conditioning. NK cell, monocyte, and
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service